Kontafarma China Holdings Ltd (1312.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 161.78M |
| Enterprise Value | 299.4M |
| P/E Ratio | -0.81 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 0.2 |
| Price/Book Ratio | 0.34 |
| Enterprise/Revenue | 0.35 |
| Enterprise/EBITDA | -17.26 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.25 |
| Operating Margin | -0.08 |
AD
Management Effectiveness
| Return On Assets | -0.21 |
| Return On Equity | -0.4 |
Income Statement
| Revenue | 914.71M |
| Revenue/Share | 0.15 |
| Gross Profit | 513.64M |
| EBITDA | -153.53M |
| Net Income | -427.85M |
| Diluted EPS | -0.08 |
Balance Sheet
| Total Cash | 67.62M |
| Total Cash/Share | 0.01 |
| Total Debt | 189.76M |
| Total Debt/Equity | 0.37 |
| Current Ratio | 0.82 |
| Book Value Per Share | 0.07 |
Price History
| 52-Week Change | -8.82 |
| 52-Week High | 0.04 |
| 52-Week Low | 0.02 |
| Moving Average 50 Days | 0.03 |
| Moving Average 200 Days | 0.03 |
Statistics
| Average Volume | 1.43M |
| Shares Outstanding | 5.58B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 5:1 |
| Last Split Date | January 20, 2015 |
AD
